Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

MindRank Secures $52M; AI-Designed Drugs Move Beyond Discovery

Artificial intelligence has taken another step from research into regulated drug development. Chinese biotech MindRank has secured $52 million in Series B funding to advance its AI-powered drug discovery platform and accelerate the clinical development of its oral GLP-1 receptor
  • News
MindRank Secures $52M; AI-Designed Drugs Move Beyond Discovery

FDA Quietly Rewrites Drug Repurposing Rules; Pharma Data Validation Suddenly Becomes Critical

The FDA is urging pharmaceutical companies to re-examine decades of clinical and real-world data using AI and advanced analytics to identify new uses for existing drugs. Published on May 29, 2026, this initiative highlights how legacy datasets may still hold
  • News
FDA Quietly Rewrites Drug Repurposing Rules; Pharma Data Validation Suddenly Becomes Critical